Roswell Biotechnologies
Roswell Biotechnologies developed the world's first molecular electronics chip, enabling precise electronic measurement at the single-molecule level for diverse applications in research and diagnostics.
Company Overview
Roswell Biotechnologies is a premier company headquartered at 11095 Flintkote Ave. Ste A, San Diego, CA 92121. The company has pioneered the world's first molecular electronics chip, the Roswell ME Chip, which integrates single molecules used as electrical sensor elements on standard semiconductor chips. This breakthrough technology enables precise electronic measurement at the single-molecule level.
Roswell ME Chip
The Roswell ME Chip is a groundbreaking innovation that integrates single molecules as electrical sensor elements on standard semiconductor chips. This allows for precise electronic measurement at the single-molecule level, applicable in various fields such as basic discovery, translational research, precision diagnostics, whole-genome sequencing, and environmental surveillance. The ME Chip platform also enables the sensing of multiple molecules on a single chip, making it useful across scientific research, clinical, industrial, and consumer applications.
Funding and Financial Backing
Roswell Biotechnologies has raised $32 million in a Series A financing round to further develop and commercialize its revolutionary molecular electronics technology. This financial backing supports the company's mission to advance its innovative platform and expand its applications across various markets.
Government Contract for DNA Data Storage
The company has been awarded a government contract for DNA digital data storage. This contract leverages Roswell Biotechnologies' molecular electronics technology to develop next-generation data storage solutions. The technology’s ability to store data at the molecular level opens new possibilities for data retention and accessibility.
Roswell ME Platform
The Roswell ME Platform is designed to integrate multiple omics disciplines—genomics, transcriptomics, epigenomics, proteomics, and metabolomics—onto a single platform. This capability has the potential to revolutionize health and scientific research by providing comprehensive, precise analyses in a unified system.